These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 23824638)

  • 41. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.
    Melchers LJ; Mastik MF; Samaniego Cameron B; van Dijk BA; de Bock GH; van der Laan BF; van der Vegt B; Speel EJ; Roodenburg JL; Witjes MJ; Schuuring E
    Br J Cancer; 2015 Apr; 112(8):1349-57. PubMed ID: 25867270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
    Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis.
    van Boerdonk RA; Daniels JM; Bloemena E; Krijgsman O; Steenbergen RD; Brakenhoff RH; Grünberg K; Ylstra B; Meijer CJ; Smit EF; Snijders PJ; Heideman DA
    J Thorac Oncol; 2013 Jun; 8(6):711-8. PubMed ID: 23571474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence Changes of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma and Effects on Survival in the Netherlands Cancer Institute, 1980-2009.
    Henneman R; Van Monsjou HS; Verhagen CV; Van Velthuysen ML; Ter Haar NT; Osse EM; Lopez-Yurda MI; Balm AJ; Van Den Brekel MW
    Anticancer Res; 2015 Jul; 35(7):4015-22. PubMed ID: 26124350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades.
    Hong A; Lee CS; Jones D; Veillard AS; Zhang M; Zhang X; Smee R; Corry J; Porceddu S; Milross C; Elliott M; Clark J; Rose B
    Head Neck; 2016 May; 38(5):743-50. PubMed ID: 25521312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status.
    Tsuchida K; Sugai T; Uesugi N; Ishida K; Matsuura K; Sato I; Shiga K; Sato H
    Oncol Rep; 2017 Aug; 38(2):908-916. PubMed ID: 28627689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
    Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma.
    Broglie MA; Jochum W; Förbs D; Schönegg R; Stoeckli SJ
    Cancer Cytopathol; 2015 Dec; 123(12):732-8. PubMed ID: 26348982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oropharyngeal squamous cell carcinoma: a unique disease on the rise?
    van Monsjou HS; Balm AJ; van den Brekel MM; Wreesmann VB
    Oral Oncol; 2010 Nov; 46(11):780-5. PubMed ID: 20920878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of human papillomavirus in the increased incidence of base of tongue cancer.
    Attner P; Du J; Näsman A; Hammarstedt L; Ramqvist T; Lindholm J; Marklund L; Dalianis T; Munck-Wikland E
    Int J Cancer; 2010 Jun; 126(12):2879-84. PubMed ID: 19856308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.